Lumida
/CORZ
⌘K
Core Scientific Inc

Core Scientific Inc

CORZ
$17.94USD+3.28%+0.57 today

MARKET CAP

5.8B

P/E (TTM)

FWD P/E

DAY RANGE

$18 – $18

52W RANGE

$13
$30

AI Summary

Stalk
Buy NowMedium

Given the Bearish Exhaustion inflection and oversold backdrop, CORZ is positioned for a mean-reversion bounce. Short-term price has reclaimed and is holding above the 9- and 20-period EMAs within the support zone, offering a favorable entry point. Medium-term bias flips bullish under mean-reversion eligibility, while long-term trend remains down, framing this as a tactical rebound. Key risks include failure to sustain above EMA support and re-test of the lower support range.

  • Polaris DS acquisition adds 440 MW capacity, targeting 590 MW by 2027
  • Liquidity of ~$1.8B funds capex and strategic site builds
  • P/E of 841.7x and negative earnings yield imply overvaluation risks
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$640.3M$502.4M$510.7M$319.0M
YoY %-21.5%+1.6%-37.5%
P / Sales7.0x14.5x
EV / Sales10.1x23.9x
Gross Profit, Adj.$8.4M$123.5M$121.1M$37.9M
YoY %+1369.8%-1.9%-68.7%
Margin %1.3%24.6%23.7%11.9%
EV / Gross Profit42.7x201.3x
EBITDA, Adj.$-19.3M$111.4M$102.0M$-155.6M
YoY %+676.5%-8.4%-252.5%
Margin %-3.0%22.2%20.0%-48.8%
EV / EBITDA50.7x-49.0x
EBIT$-1.3B$15.3M$-11.2M$-256.3M
YoY %+101.2%-172.8%-2192.9%
Margin %-203.6%3.1%-2.2%-80.3%
EV / EBIT-462.8x-29.8x
Net Income$-2.1B$-246.5M$-1.2B$-280.7M
YoY %+88.5%-405.2%+77.5%
Net Margin-335.2%-49.1%-243.9%-88.0%
EPS (GAAP)-$6.30-$0.65-$4.87-$0.88
YoY %+89.7%-649.2%+81.9%